NextLeap Ventures

NextLeap Ventures is a venture capital firm based in Herzliya, Israel, with an additional office in the United States. Founded in 2017, it focuses on supporting early-stage technology startups in Israel and seeks investments across information technology, machine learning and artificial intelligence, digital health, Industry 4.0 and IoT, as well as cybersecurity and manufacturing sectors.

Ido Lapidot

Co-Founder and Partner

Ido Lapidot

Partner

19 past transactions

Cybord

Series A in 2024
Cybord develops technology to prevent counterfeit, defective, or malicious electronic components from being assembled into products during manufacturing. It integrates with manufacturing equipment, using deep learning algorithms and a global component database to rate each component.

Carrar

Series A in 2024
Carrar specializes in the manufacturing of advanced battery systems for electric vehicles, emphasizing exceptional heat dissipation to enhance performance and longevity. The company's innovative thermal management system employs novel two-phase immersion cooling technology, which enables precise temperature control throughout the battery pack, ensuring uniformity at both the cell circumference and interior. This closed-loop system effectively manages the fluid boiling point, allowing for flexible control and sustained temperatures, ultimately increasing overall battery efficiency. By improving cooling mechanisms, Carrar's battery systems significantly reduce the Total Cost of Ownership for commercial vehicles and enhance the return on investment for passenger cars, contributing to superior battery performance and extended operational lifespans.

CorrActions

Series A in 2023
CorrActions develops an AI-driven platform that interprets and translates human brain signals in real-time. This enables smarter machines across aviation, automotive, medical, and tech industries, enhancing human-machine interaction efficiency.

Enzymit

Seed Round in 2022
Enzymit is a biotechnology company focused on revolutionizing global manufacturing through sustainable and efficient bio-production methods. It specializes in developing cell-free bio-production technology that aims to eliminate the inefficiencies and complexities associated with traditional bio-production. Enzymit employs artificial intelligence and deep learning algorithms to design novel enzymes, which serve as molecular machines capable of transforming abundant feedstocks into valuable products, including pharmaceuticals, cosmetics, food, and materials. The company’s small, modular bio-reactors facilitate this process, promoting resource independence while minimizing environmental impact. By moving away from conventional whole-cell methods to utilizing nature's elemental building blocks, Enzymit enhances cost-effectiveness, efficiency, and sustainability in bio-production, while also providing greater flexibility in product customization for various industries.

Cybord

Seed Round in 2022
Cybord develops technology to prevent counterfeit, defective, or malicious electronic components from being assembled into products during manufacturing. It integrates with manufacturing equipment, using deep learning algorithms and a global component database to rate each component.

ShieldIoT

Series A in 2021
ShieldIoT is an Israeli company based in Tel Aviv, founded in 2017, specializing in IoT embedded device-level security solutions. Their flagship product, ShieldIOT, is a technology platform that protects Linux-based devices across IoT networks without requiring changes to the device, application, or network. The platform comprises ShieldCenter, a centralized security management module, and ShieldSupervisor, a device-level agent module. ShieldIoT offers comprehensive security features including application sandboxing, device resource protection, firewall, VPN secured communication, disk encryption, fleet monitoring, and threat prevention. These solutions cater to various industries such as smart homes, healthcare, transportation, retail, and more, enabling manufacturers and operators to secure their devices efficiently without needing extensive development resources or security expertise.

NewPhotonics

Seed Round in 2021
NewPhotonics specializes in designing Photonic Integrated Circuits (PICs) and optical modules to revolutionize optical communications in data centers. Their innovative Photonics Engines significantly reduce power consumption, improve reliability, and eliminate data rate bottlenecks for compute and AI workloads.

TechsoMed

Series B in 2021
TechsoMed is an Israeli medical device company specializing in the development of ultrasound-based real-time monitoring systems for thermal ablation procedures. These procedures have wide-ranging applications, including tumor destruction, treatment of heart arrhythmias, and blood pressure management. Despite a market size in the billions, these procedures often suffer from high failure rates due to the lack of real-time monitoring capabilities. TechsoMed's technology addresses this issue by providing physicians with the ability to monitor tissue destruction in real time, thereby enhancing the effectiveness of these minimally invasive and cost-effective treatments for patients, physicians, and insurance companies alike.

DataLoop

Series A in 2020
Founded in 2017, DataLoop specializes in developing artificial intelligence products for data automation. It provides visual recognition solutions and data annotation services, streamlining the process of preparing visual data for machine learning.

HT BioImaging

Grant in 2020
HT BioImaging Ltd. is an innovative company specializing in medical imaging technology focused on the early detection of oral cancer. Founded in 2015 and headquartered in Ganei Am, Israel, the company has developed the HTOScan, a device that utilizes heat diffusion imaging combined with artificial intelligence to analyze tissue. This technology measures the heat diffusion and dissipation within the examined tissue, producing images that indicate the likelihood of cancer. HT BioImaging aims to provide a non-invasive, real-time diagnostic tool for clinicians, allowing for the detection and classification of cancerous tissues directly in community clinics and operating rooms. The company’s team consists of experts in AI, signal analysis, computer vision, and oncology, working together to advance cancer detection methods.

Nanofabrica

Venture Round in 2020
Nanofabrica is a pioneering company based in Tel Aviv, Israel, specializing in 3D printing technology for precision manufacturing. Founded in 2016, the company focuses on micro and nanomanufacturing, offering solutions for various sectors, including semiconductors, optics, and medical devices. Its innovative Micro Adaptive Projection technology enables the production of ultra-precise and complex parts with an unprecedented micron-resolution. This capability allows for rapid manufacturing of high-performance components, significantly reducing costs and time compared to traditional methods. By integrating advanced optics and semiconductor lithography with 3D printing, Nanofabrica serves mass customization needs, responding to customer feedback to continuously refine its technology and expand into new markets such as robotics and biomedical applications.

Concertio

Seed Round in 2020
Concertio Inc., founded in 2016 and based in New York, is a leading provider of artificial intelligence-powered performance optimization tools for hardware and software systems. The company's flagship product, Concertio Optimizer, monitors and learns from interactions between applications and systems to optimize their performance dynamically. This tool includes Optimizer Studio, designed for performance engineers and IT professionals, and Optimizer Runtime, which provides real-time optimization. By tailoring system settings in processors, firmware, OS, and applications to specific workloads, Concertio's tools enhance the efficiency of computing systems, turning general-purpose systems into high-performant special-purpose ones. The company's clients include major tech firms like Intel, Marvell, and Mellanox.

Geneyx

Seed Round in 2020
Geneyx develops AI-driven analytics platforms to facilitate secure genetic data analysis and improve clinical diagnostics. By collaborating with global healthcare providers, they aim to enhance genetic testing capabilities and accelerate accurate patient diagnoses.

DataLoop

Seed Round in 2019
Founded in 2017, DataLoop specializes in developing artificial intelligence products for data automation. It provides visual recognition solutions and data annotation services, streamlining the process of preparing visual data for machine learning.

Concertio

Seed Round in 2019
Concertio Inc., founded in 2016 and based in New York, is a leading provider of artificial intelligence-powered performance optimization tools for hardware and software systems. The company's flagship product, Concertio Optimizer, monitors and learns from interactions between applications and systems to optimize their performance dynamically. This tool includes Optimizer Studio, designed for performance engineers and IT professionals, and Optimizer Runtime, which provides real-time optimization. By tailoring system settings in processors, firmware, OS, and applications to specific workloads, Concertio's tools enhance the efficiency of computing systems, turning general-purpose systems into high-performant special-purpose ones. The company's clients include major tech firms like Intel, Marvell, and Mellanox.

GuardKnox

Series A in 2019
GuardKnox is an automotive technology company that specializes in developing high-performance, secure, and customizable solutions for software-defined vehicles. Founded in 2016 and headquartered in Israel, with additional offices in Munich, Germany, and Detroit, Michigan, GuardKnox focuses on providing scalable technologies that enhance vehicle connectivity. The company's platform enables consumers to personalize their vehicle's performance and in-vehicle experience through its advanced firmware and software components, which are designed for high-speed and low-latency operation. By prioritizing secure-by-design practices, GuardKnox aims to assist clients in efficiently bringing innovative applications and services to market, ultimately improving the overall mobility experience.

TechsoMed

Venture Round in 2019
TechsoMed is an Israeli medical device company specializing in the development of ultrasound-based real-time monitoring systems for thermal ablation procedures. These procedures have wide-ranging applications, including tumor destruction, treatment of heart arrhythmias, and blood pressure management. Despite a market size in the billions, these procedures often suffer from high failure rates due to the lack of real-time monitoring capabilities. TechsoMed's technology addresses this issue by providing physicians with the ability to monitor tissue destruction in real time, thereby enhancing the effectiveness of these minimally invasive and cost-effective treatments for patients, physicians, and insurance companies alike.

Magentiq Eye

Seed Round in 2018
Magentiq Eye Ltd., established in 2014, specializes in developing AI-driven medical devices for endoscopic procedures. Its flagship product is the Automatic Polyp Detection System (APDS), which uses computer vision and deep learning to assist doctors in real-time colonoscopy examinations, aiming to reduce polyp miss-rates and improve patient outcomes.

Sanolla

Seed Round in 2016
Sanolla is a digital healthcare company developing smart medical diagnosis solutions. Utilizing AI-powered detection and analysis of previously inaccessible body infrasounds, their affordable, non-invasive products enable immediate and accurate patient assessments, reducing clinic visits and lowering infection risks.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.